

MVZ Martinsried -
Service, Qualität und Innovation
GUIDELINE FOR VARIANT CLASSIFICATION
The ACMG classification system is used to classify sequence variants for mendelian diseases, regardless of whether variants were detected by Sanger sequencing or NGS (Next Generation Sequencing).
Variants are separated into 5 classes according to IARC recommendations (Plon et al. 2008):
class 1 benign
class 2 likely benign
class 3 variant of uncertain significance (VUS)
class 4 likely pathogenic
class 5 pathogenic
The following 3 chapters are based on the literature mentioned below and provide a schematic overview of the ACMG classification system. For detailed information we recommend reading the complete publications.
Chapter 1 lists all ACMG-criteria supporting pathogenicity and chapter 2 lists all ACMG-criteria supporting benignity. In order to classify a sequence variant into one of the five classes, the corresponding criteria are combined according to the table in chapter 3.
1. Criteria for pathogenic evidence














2. Criteria for benigne evidence












3. Rules for combining criteria to classify sequence variants

Literatur
Ellard et al. 2020, ACGS Best Practice Guidelines for Variant Classification 2020 / Abou Tayoun et al. 2018, Hum Mutat 39:1517 / Richards et al. 2015, Genet Med 17:405 / Jarvik et Browning 2016, AJHG 98:1077 / Plon et al. 2008, Hum Mutat 29:1282